Patents by Inventor Elad Jacoby

Elad Jacoby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12605410
    Abstract: The present invention is based on the discovery that cells enriched with mitochondria are useful for treating diseases and disorders. Disclosed are pharmaceutical compositions of mitochondrially-enriched genetically engineered T cells and methods of treatment using mitochondrially-enriched genetically engineered T cells.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: April 21, 2026
    Assignees: Minovia Therapeutics Ltd., Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Natalie Yivgi-Ohana, Noa Sher, Moriya Blumkin, Elad Jacoby
  • Publication number: 20250353892
    Abstract: Provided herein are compositions comprising T cells expressing a recombinant virus-specific T cell receptor (rTCR-V) specific for a viral antigen restricted by a predetermined HLA type, rTCR-Vs, methods for preparing them, their use for treatment, and libraries containing such rTCR-V or T cells comprising them.
    Type: Application
    Filed: June 6, 2023
    Publication date: November 20, 2025
    Inventors: Gal CAFRI, Nira VARDA-BLOOM, Elad JACOBY, Amihai LIEBERMAN, Neta ZUCKERMAN, Ayal HENDEL, Nimrod BEN HAIM
  • Publication number: 20250319182
    Abstract: Provided herein are compositions comprising isolated T cells specific for one or more viral antigens derived from viruses such as adenovirus (ADV), cytomegalovirus (CMV), BK virus (BKV), Epstein-Barr virus (EBV), human herpes virus 6 (HHV6), John Cunningham virus (JC), or human immunodeficiency virus (HIV), methods for obtaining them, libraries including them, and uses thereof in treating viral infections.
    Type: Application
    Filed: June 6, 2023
    Publication date: October 16, 2025
    Inventors: Gal CAFRI, Elad JACOBY, Amihai LIEBERMAN, Neta ZUCKERMAN, Nira VARDA-BLOOM
  • Publication number: 20230123731
    Abstract: The present invention is based on the discovery that cells enriched with mitochondria are useful for treating diseases and disorders. Disclosed are pharmaceutical compositions of mitochondrially-enriched genetically engineered T cells and methods of treatment using mitochondrially-enriched genetically engineered T cells.
    Type: Application
    Filed: March 30, 2021
    Publication date: April 20, 2023
    Inventors: Natalie Yivgi-Ohana, Noa Sher, Moriya Blumkin, Elad Jacoby